Search clinical trials for: Excitatory Amino Acids

Total 24088 results

National Institute of Mental Health (NIMH)

Completed

Clinical Trial of Felbamate for Treatment-Resistant Bipolar Depression

Bipolar Disorder

United States
BrainCells Inc.

Completed

A Multiple Ascending Dose Study of BCI-838 in Healthy Volunteers

Healthy

Netherlands
Emory University

Completed

Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation

Inflammation | Fatigue

United States
King's College London
South London and Maudsley NHS Foundation Trust

Recruiting

The Role of Glutamatergic Function in the Pathophysiology of Treatment-resistant Schizophrenia (RESTORE)

Treatment-resistant Schizophrenia | Healthy Controls | Treatment-responsive Schizophrenia

United Kingdom
University Hospital, Caen

Completed

Excitotoxicity Markers and the Clinical-radiological Progression After a Demyelinating Event: a Prospective Pilot Study (EXCEED)

Multiple Sclerosis
National Institute of Mental Health (NIMH)

Completed

Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders

Obsessive-Compulsive Disorder | Autism Spectrum Disorder | Autism | Asperger Disorder | Developmental Disorder

United States
Hospital de Clinicas de Porto Alegre

Unknown

Therapeutic Efficacy of Oral L-Ornithine-L-Aspartate on Minimal Encephalopathy (PORTOALEGRE)

Hepatic Encephalopathy

Brazil
National Institute of Mental Health (NIMH)

Completed

Riluzole to Treat Major Depression

Depression

United States
Mclean Hospital

Completed

Riluzole in the Treatment of Bipolar Depression

Bipolar Depression

United States
Air Force Military Medical University, China

Completed

The Effectiveness of L-ornithine-L-aspartate (LOLA) on Plasma Ammonia in Cirrhotic Patients After TIPS

Decompensated Cirrhosis | Portal Hypertension | Bleeding Varices | Refractory Ascites

China
All India Institute of Medical Sciences, New Delhi

Unknown

Therapeutic Efficacy of L-Ornithine L-Aspartate Infusion in Patients With Acute Liver Failure

Acute Liver Failure

India
Ain Shams University

Recruiting

Efficacy of L-Ornithine L-Aspartate (LOLA) as an Adjunct to Branched Chain Amino Acids (BCAA) Enriched Solutions on Clinical Outcomes in ICU Patients With Hepatic Encephalopathy

Hepatic Encephalopathy

Egypt
Institute of Liver and Biliary Sciences, India

Not yet recruiting

Efficacy of L-ornithine L-aspartate and Therapeutic Plasma Exchange Versus Plasma Exchange Alone in Lowering Ammonia and Improving Outcomes in Pediatric Acute Liver Failure.

Liver Failure, Acute

India
National Institute of Neurological Disorders and...

Completed

Treatment of Parkinson's Disease With Eliprodil

Parkinson Disease | Movement Disorders

United States
Aga Khan University

Completed

Efficacy of L-Ornithine-L-Aspartate in Cirrhotics With Hepatic Encephalopathy

Hepatic Encephalopathy

Pakistan
Yale University

Completed

Efficacy and Tolerability of Riluzole in Treatment Resistant Depression

Depression

United States
PNA Center for Neurological Research
Eisai Inc.

Unknown

Fycompa in Subjects With Small Fiber Neuropathy (SFN)

Neuropathy, Small Fiber

United States
Imperial College London
University of London; Royal College of Physicians; Paddington Charitable Estates...

Completed

Brain Imaging in Patients With Chronic Liver Disease and Functional Impairment.

Hepatic Encephalopathy | Cirrhosis

United Kingdom
Medical University of Graz
CBmed Ges.m.b.H.

Recruiting

Effect of L-ornithine-L-aspertate (LOLA) on the Gut Microbiome (LOLAbiome)

Cirrhosis

Austria
National Institute of Mental Health (NIMH)

Terminated

Riluzole to Treat Depression in Bipolar Disorder

Bipolar Disorder

United States
New York State Psychiatric Institute

Completed

Glutamatergic Modulation of Motivation Enhancement: A Pilot Feasibility Trial

Cocaine Use Disorders

United States
Yale University

Completed

Functional Neuroimaging of Alcoholism Vulnerability (PIT) (CTNA)

Healthy

United States
Yale University
National Institute of Mental Health (NIMH)

Completed

Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder

Obsessive-compulsive Disorder | Ocd

United States
National Taiwan University Hospital

Unknown

Memantine add-on for Cognitive and Negative Symptoms of Schizophrenia

Schizophrenia

Taiwan
National Institute of Neurological Disorders and...

Completed

Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous System

Parkinson's Disease | Neurodegenerative Disease

United States
Johns Hopkins University
National Institute of Mental Health (NIMH)

Completed

Developing New Treatments for Tourette Syndrome: Therapeutic Trials With Modulators of Glutamatergic Neurotransmission

Tourette Syndrome

United States
State University of New York at Buffalo

Enrolling by invitation

Repurposing Lithium for Parkinson's Disease

Parkinson's Disease

United States
King's College London

Unknown

Memantine and Down's Syndrome

Dementia | Learning Disabilities | Down's Syndrome

United Kingdom
Assiut University

Completed

Effect of Memantine on Cognitive Impairment in Patients With Epilepsy

Epilepsy

Egypt
University Hospital, Lille

Completed

Study of Memantine for Gait Disorders And Attention Deficit In Parkinson's Disease (FOGG-I)

Parkinson's Disease | Gait Disorders, Neurologic

France
Assiut University

Recruiting

Memantine Hydrochloride for Treatment of Cognitive Dysfunction Due to Traumatic Brain Injury

Treatment of Posttraumatic Cognitive Dysfunction

Egypt
Centro Regional para el Estudio de las Enfermedades...
MERZ PHARMA

Completed

Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.

Hepatic Encephalopathy

Mexico
Dayanand Medical College and Hospital

Completed

L-ornithine L-aspartate in Overt Hepatic Encephalopathy (HEAL)

Hepatic Encephalopathy | Cirrhosis of Liver

India
National Institute of Mental Health (NIMH)

Completed

Clinical Trial of Memantine for Major Depression

Depression

United States
BrainCells Inc.

Completed

A Study of BCI-838 and Several BCI-632 Prodrugs in Healthy Volunteers

Healthy

Netherlands
Sanofi

Terminated

Effect of Chronic Supplementation of L-arginine in the Muscular Performance

Muscular Fatigue

Brazil
Mahidol University

Completed

Efficacy of Combined Oral L-ornithine-L-aspartate and Lactulose in Patients With Hepatic Encephalopathy

Hepatic Encephalopathy

Thailand
University of Washington
Forest Laboratories

Unknown

Memantine for Post-Operative Pain Control

Pain, Post-operative

United States
Northwestern University

Completed

Does a Single Intravenous Dose of Ketamine Reduce the Need for Supplemental Opioids in Post-Cesarean Section Patients?

Ketamine Adverse Reaction | Effects of; Anesthesia, Spinal and Epidural, in Pregnancy | Complication of Labor and/or Delivery

United States
AB Science

Recruiting

Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

Amyotrophic Lateral Sclerosis

France, Spain, United States, Sweden, Denmark, Portugal, Italy, Israel, Germany, Norway, Poland, Russian Federation, Slovenia, Ukraine, Greece, Belgium, Serbia
King Abdullah International Medical Research Center

Unknown

Effect of N-methyl D-aspartate (NMDA) Receptor Antagonist Dextromethorphan on Opiods Analgesia and Tolerance in Pediatric Intensive Care Unit Patients

Pain | Opioid Tolerance | Analgesia Tolerance

Saudi Arabia
M. Schaefer, MD
Stanley Medical Research Institute

Terminated

Memantine for the Prevention of Cognitive Dysfunction and Negative Symptoms in Patients With Acute Schizophrenia

Schizophrenia

Germany
National Taiwan University Hospital

Unknown

Effect of Memantine on ERP in Early Schizophrenia and Healthy Subjects

Schizophrenia

Taiwan
Yale University
National Institute of Mental Health (NIMH); American Psychiatric Association

Completed

Examining The Effect Of Ketamine On Glutamate/Glutamine Cycling

Depression

United States
Yale University
AstraZeneca

Completed

Parallel Effects of Schizophrenia and N-methyl-D-aspartate (NMDA) Antagonism

Schizophrenia

United States
Mayo Clinic

Active, not recruiting

Ketamine Associated ACC GABA and Glutamate Change and Depression Remission:

Bipolar Depression | Major Depressive Disorder | Treatment Resistant Depression

United States
New York State Psychiatric Institute
New York Presbyterian Hospital

Completed

Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD)

Obsessive-Compulsive Disorder

United States
Jinnah Postgraduate Medical Centre

Not yet recruiting

Efficacy of L-Ornithine L-Aspartate and Polyethylene Glycol in Cirrhotic Patients With Overt Hepatic Encephalopathy

Hepatic Encephalopathy Stage 2 | Hepatic Encephalopathy Stage 3 | Hepatic Encephalopathy Stage 4

Pakistan
James Murrough

Completed

Intranasal Ketamine in Treatment-Resistant Depression

Major Depressive Disorder

United States
Yale University
National Alliance for Research on Schizophrenia and Depression

Completed

Ketamine Infusion for Obsessive-Compulsive Disorder

Obsessive-compulsive Disorder

United States

Search clinical trials for: Excitatory Amino Acids

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations